Congress-ISPOR
Glasgow-uk-mobile

Cardiovascular (CV)

European Renal Association (ERA) 2026

Congress Details

calanderJune 3-6, 2026

locationGlasgow, Scotland

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Agenda

04 June, 2026

Image
icon Presentation Type
Oral presentation
Image
time icon Time
16:54 - 17:00 BST
Image
location icon Location
Focused Oral Room 12​
Image
icon Title
Zilebesiran as Add-on Treatment to RAAS Inhibitors for Patients with Hypertension: Data From KARDIA-2 and KARDIA-3 Phase 2 Trials
mic Presenter

David Wheeler
University College London, UK

05 June, 2026

Coming soon
Image
icon Presentation Type
Standard Presentation
Image
time icon Time
8:15 - 8:33 BST
Image
location icon Location
The Square
Image
icon Title
Zilebesiran as Add-on Treatment to RAAS Inhibitors for Patients with Hypertension: Data From KARDIA-2 and KARDIA-3 Phase 2 Trials
mic Presenter

David Wheeler
University College London, UK